Griet Nuytinck

President bij Muziekcentrum De Bijloke Gent

Health Technology

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Daniel Vuijlsteke	M	-	Muziekcentrum De Bijloke Gent	-
Christian Cardon	M	56	Ziphius Vaccines NV Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.	5 jaar
Olivier Lemaire	M	-	Ziphius Vaccines NV Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.	-
Marina Hoornaert	F	-	Muziekcentrum De Bijloke Gent	-
Annie Vereecken	F	-	Ziphius Vaccines NV Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.	-
Bart Vandesompele	M	-	Muziekcentrum De Bijloke Gent	-
Tom Almey	M	-	Ziphius Vaccines NV Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.	-
Johan Van Hoof	M	-	Ziphius Vaccines NV Ziphius Vaccines NV BiotechnologyHealth Technology Ziphius Vaccines NV is a Belgian biopharmaceutical company that specializes in developing vaccines and therapeutics using its proprietary self-amplifying RNA and carrier technology platforms. The private company is based in Ghent, Belgium and has a portfolio of next-generation vaccine candidates that target infectious diseases and gene supplementation therapies. The company's lead compound, Zip1642, is a COVID-19 vaccine candidate that has undergone preclinical studies. The company was founded in 2019 by Christian Cardon, who has been the CEO since then.	-
Hilde Allaert	M	-	Muziekcentrum De Bijloke Gent	-
Frank Beke	M	-	Muziekcentrum De Bijloke Gent	-
Fourat Ben Chikha	M	-	Muziekcentrum De Bijloke Gent	-
Paco Collumbien	M	-	Muziekcentrum De Bijloke Gent	-
Johan Deckmyn	M	-	Muziekcentrum De Bijloke Gent	-
Karlijn Deene	F	-	Muziekcentrum De Bijloke Gent	-
Daan Schalck	M	-	Muziekcentrum De Bijloke Gent	-